$13.640
+0.861 (+6.31%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ABCL Prediction & Forecast by Similar Chart Analysis
Alphio's ABCL stock price prediction model matches the current AbCellera Biologics Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.86 (+1.61%). The 1-week path is $14.06 (+3.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy AbCellera Biologics Inc. Stock?
Abcellera Biologics Inc is a good buy right now. The current price is $11.82, with a forward P/E of 27.55, indicating growth potential despite recent losses. The stock has seen a 244.61% year-to-date change, reflecting strong market interest. The main risk is the negative net income, which was -$55,427,000 in Q2 2026, but the positive analyst outlook and clinical success suggest potential for recovery.
ABCL stock price ended at $13.64 on Wednesday, after rising +6.31%
AbCellera Biologics Inc. (ABCL) last closed at $13.6400003, gaining +6.31%. These facts feed the 1-day and 1-week ABCL price prediction above.
Forecast Drivers
AbCellera Biologics Inc. (ABCL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ABCL, ranked by similarity.
Seasonality analysis for ABCL
Historically the probability of a positive October return for ABCL is 65.67%. September offers the highest probability of a positive month at 67.74%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ABCL
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $1.11 | $1.60 | $1.84 | -88.23% |
| Nov 2026 | $2.00 | $2.06 | $2.54 | -84.88% |
| Dec 2026 | $1.71 | $1.76 | $2.25 | -87.10% |
In 2026, AbCellera Biologics Inc. (ABCL) is projected to range from $1.11 to $2.54.
AbCellera Biologics Inc. 2026 monthly forecast
In Oct 2026, AbCellera Biologics Inc. is projected to average $1.60, with a low of $1.11 and high of $1.84.
In Nov 2026, AbCellera Biologics Inc. is projected to average $2.06, with a low of $2.00 and high of $2.54.
In Dec 2026, AbCellera Biologics Inc. is projected to average $1.76, with a low of $1.71 and high of $2.25.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.